Rockefeller Capital Management
ABEO icon

Rockefeller Capital Management’s Abeona Therapeutics ABEO Stock Holding History

Rockefeller Capital Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.72K Hold
1,250
– – ﹤0.01% 4108
2026
Q1 		$5.6K Hold
1,250
– – ﹤0.01% 4206
2025
Q4 		$6.59K Hold
1,250
– – ﹤0.01% 3977
2025
Q3 		$6.6K Buy
+1,250
New +$7.93K ﹤0.01% 3794
2023
Q1 		– Sell
-1,500
Closed -$4K – 1975
2022
Q4 		$4K Buy
+1,500
New +$5.61K ﹤0.01% 3359
2020
Q4 		– Sell
-160
Closed -$4K – 2830
2020
Q3 		$4K Buy
+160
New +$10.1K ﹤0.01% 2258

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Rockefeller Capital Management's ABEO Position: Q2 2026 in Review

Rockefeller Capital Management held its Abeona Therapeutics (ABEO) position steady in Q2 2026 at 1,250 shares worth $7.72K. The position accounts for ﹤0.01% of the portfolio, ranked #4108.

Rockefeller Capital Management first reported a position in ABEO in Q3 2020 and has held it in 6 quarters since. 126 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • Rockefeller Capital Management held 1,250 shares of Abeona Therapeutics worth $7.72K as of Q2 2026.
  • Rockefeller Capital Management left its Abeona Therapeutics share count unchanged in Q2 2026.
  • Abeona Therapeutics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4108 holding.
  • Rockefeller Capital Management first reported a position in Abeona Therapeutics in Q3 2020 and has held it in 6 quarters since.
  • 126 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.